The challenge of merging Ranbaxy into the company has not been factored in.
Softening rural consumption and the likelihood of weak corporate earnings in the March quarter saw investors dump stocks.
Only six sectors are likely to report good set of numbers in Q4 FY15.
The market direction will be guided by corporate earnings, especially the oil & gas companies, since they were responsible for earnings disappointment in the past quarter as well.
It was a year of big gains for equity investors.
Global events will continue to be in the limelight, besides domestic policy.
Real test of the rally in this segment will be the upcoming result season.
Given the better growth in JLR sales and improving domestic sales, nearly 90 per cent of the analysts covering the stock have a 'Buy' rating.
Ashok Leyland, ITD Cementation India have more than doubled.
Pharma stocks have performed well after Budget
Hike in planned public-sector capital expenditure will be credit-positive for infra cos
There is a lot of optimism as regards the defence, railway and manufacturing sectors.
AAP has promised lower electricity bills, free basic water supply.
Can the poll outcome be a trigger for a meaningful correction?
BJP loss could trigger a correction
HDFC and HUL are the latest entrants in the club
Half of the sharp rise in stocks in 2014 was driven by re-ratings - rise in price-to-earning ratios on hopes the new government would turn around the economy which will reflect in corporate earnings.
With a rise of around 30 per cent in the benchmark index S&P BSE Sensex, 2014 has been the best year for Indian equity markets since 2009, when the benchmark index surged 81 per cent.
Maruti has improved its sales in the recent past.
Have a Plan B in place if the tide turns against you.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances